Browse by Audience
MEMBER

Update Your Profile
Member Spotlights
Refer a Member: IASP Champions
Join a Special Interest Group (SIG)
Find a Chapter
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Papers of the Week
Webinars and Podcasts
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Webinars & Podcasts
Curricula
Graduate Opportunities
Events

PATIENT & CAREGIVER

RELIEF News
Resources for Living with Pain
Global Alliance of Partners in Pain Advocacy (GAPPA)
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner

gy2022-1-3
I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / Risankizumab-rzaa: A New Therapeutic Option for the Treatment of Crohn’s Disease.

< BACK TO ARCHIVE


2022 Oct 08


Ann Pharmacother


http://www.ncbi.nlm.nih.gov/pubmed/36214282?dopt=Abstract

Risankizumab-rzaa: A New Therapeutic Option for the Treatment of Crohn’s Disease.

Authors

Risankizumab-rzaa: A New Therapeutic Option for the Treatment of Crohn's Disease.
Choi D, Sheridan H, Bhat S
Ann Pharmacother. 2022 Oct 08:10600280221130450.
PMID: 36214282.

Abstract

To review the pharmacologic and clinical profile of risankizumab-rzaa in the treatment of Crohn's disease (CD).
Read This Paper